Nabriva Therapeutics PLC

Nabriva Therapeutics PLC is a biopharmaceutical company focused on developing and commercializing innovative anti-infective agents to treat serious infections. The company concentrates its efforts on addressing the growing unmet needs of patients suffering from life-threatening infections, particularly those caused by resistant bacteria. Nabriva's research and development activities are geared towards discovering, developing, and commercializing novel therapies that offer improved efficacy, safety, and convenience compared to existing treatment options. The company operates within the pharmaceutical industry, specifically the sector focused on infectious diseases and antibiotic resistance. By developing new and effective anti-infectives, Nabriva aims to contribute to the global fight against antibiotic resistance and improve patient outcomes in the treatment of serious infections. Nabriva Therapeutics is committed to addressing the challenges posed by evolving bacterial resistance.